Endo Provides Update On OPANA® ER - PR Newswire (press release)

Washington Post

Endo Provides Update On OPANA® ER PR Newswire (press release) DUBLIN, July 6, 2017 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) continues to believe in the safety, efficacy, and favorable benefit-risk profile of OPANA® ER (oxymorphone hydrochloride extended release) when used as intended, and notes ... Endo | Press ReleasesEndo Pharmaceuticals all 83 news articles »

from Health - Google News http://ift.tt/2u3gMWr